Virus-specific RNA synthesis in interferon-treated mouse cells productively infected with Moloney murine leukemia virus

Two interferon sensitive steps in the replication cycle of Rous sarcoma virus

De novo infection of Rous sarcoma virus (RSV) strains of receptor subgroups A, B, C, and D is inhibited by low doses of chick interferon. Adsorption and penetration into the cell are not marginally impaired by interferon treatment. Since the level of proviral DNA synthesis is strongly reduced in the interferon-treated cell it is concluded that uncoating or reverse transcription of the viral genome is inhibited. This inhibition of proviral DNA synthesis is not caused by an arrest of CEF in the stationary phase. Chronic infection of SR-RSV-A, -B, -C, but not SR-RSV-D is also sensitive to interferon. Chick interferon treatment (50 u/ml) also had no inhibitory effect on the amount of transcripts of the RSV-specific oncogene src or the cellular oncogenes src and myc.

Construction and characterization of Moloney murine leukemia virus mutants unable to synthesize glycosylated gag polyprotein

Murine leukemia virus (MuLV) encodes two independent pathways for expression of the gag gene. One pathway results in processing and cleavage of the precursor Pr65gag to yield the internal capsid proteins of the virion and is analogous to gag polyprotein precursors for all classes of retroviruses. The other pathway, which is not encoded by several other classes of retroviruses, begins with a glycosylated polyprotein gPr80gag . gPr80gag is synthesized independently of Pr65gag; it contains Pr65gag peptides and additional amino-terminal protein. It is modified by further addition of carbohydrate, exported to the cell surface, and released from the cell but does not appear in virus particles. To investigate the role of glycosylated gag in MuLV infection, two mutants of Moloney MuLV (M-MuLV) deficient for synthesis of gPr80gag but able to synthesize Pr65gag were constructed. The mutants were obtained by substitution into a molecular clone of M-MuLV DNA by DNA from two acutely transforming viruses, Ableson MuLV (Ab-MuLV) and Moloney murine sarcoma virus (M-MSV). Both Ab-MuLV and M-MSV are derived from M-MuLV and they express M-MuLV gag sequences, but some strains do not synthesize glycosylated gag protein. For Ab-MuLV, a 177-base-pair Pst I fragment from the P90 strain containing the initiation codon for Pr65gag was substituted for the equivalent fragment in M-MuLV DNA. For M-MSV, 1.5 kilobases at the 5' end of the genome was substituted. Transfection of the recombined DNAs onto NIH-3T3 cells produced infectious M-MuLV, although the infected cells did not produce gPr80gag. Therefore glycosylated gag is not absolutely required for MuLV replication. Deletion of the glycosylated gag pathway did not significantly reduce the level of virus production, although a minor difference in XC plaque morphology was observed.

Effect of interferon on multiplication of avian sarcoma virus B77 in duck embryo fibroblasts

The effect of interferon on the multiplication of the avian sarcoma virus B77 in duck embryo fibroblasts was studied. The interferon used for this purpose as induced in duck embryo fibroblasts by high multiplicities of reovirus serotype 3 (strain Dearing) and purified to a specific activity of at least 2 x 10(7) units/ml (estimated to be at least 10% pure). Treatment of duck embryo fibroblasts transformed with B77 virus with as little as 50 units/ml of this interferon caused a rapid inhibition of the release of virus particles, and a decrease in the specific infectivity of the virus particles that were released of about six-fold. The protein composition of virus particles released from normal and interferon-treated duck embryo fibroblasts was not detectably different. Examination of the nature of the virus-specified proteins, as determined by precipitation with specific antisera, synthesized at various times after treatment of transformed duck embryo fibroblasts with 300 units/ml of interferon revealed the following major changes: i. a more than 5-fold increase in the amount of a protein with a molecular weight of about 100,000 (P100) precipitated by antiserum to reverse transcriptase. This increase was paralleled by a decrease in the amount of the gag-pol precursors Pr190 and Pr180, but the amount of the alpha and beta subunits of reverse transcriptase was not altered by interferon treatment. ii. An at last 3-fold increase in the amount of cell-associated gag proteins. iii. A two- to ten-fold decrease in the amount of a protein with an apparent molecular weight of 76,000, in all likelihood Pr76, precipitated by antiserum to gp85. The primary cause of the interferon-induced inhibition of virus particle release appears to be inability of Pr76 to associate with gPr95/gp85 in plasma cell membranes.

Characterization of intracellular viral RNA in interferon-treated cells chronically infected with murine leukemia virus

We have recently found that Moloney murine leukemia virus assembles within cytoplasmic vacuoles of chronically infected NIH/3T3 cells rather than at their surface (submitted for publication). In the present study we found that if these cells were treated with interferon (IF) for 24 to 48 h the intracellular virus particles accumulated at a two- to threefold-higher level than that observed in untreated cells. Nevertheless, despite this accumulation, no difference between IF-treated and untreated cells was observed in the amount of the total cytoplasmic viral RNA or in its 35S or 21S species. When cellular virions were sedimented from the cytoplasmic fraction, a markedly higher amount of viral RNA was detected in the viral pellet of IF-treated cells than was detected in untreated cells, whereas the amount of viral RNA left in the virus-free cytoplasm of IF-treated cells was much lower than that in the untreated cells. Furthermore, the amount of the cytoplasmic polyriboadenylic acid-containing viral RNA was also remarkably higher in the IF-treated cells. Viral polyribosomes appeared to be fully functional in IF-treated cells, since no effect of IF on viral protein synthesis could be detected. Analysis of the nuclear viral RNA showed no difference between IF-treated and untreated cells after 24 h of IF treatment. Both contained a comparable amount of 35S viral RNA. However, at 48 h a significant accumulation of viral RNA was observed in the nucleus of the IF-treated cells as compared with the untreated cells, although in both cases only 35S species were evident. This accumulation appeared to activate a degradation process which destroyed nuclear viral RNA, since a dramatic shift toward smaller-sized molecules of viral RNA and a remarkable reduction in its amount were observed after 72 h of IF treatment.

Interferon induced inhibition of mouse mammary tumor virus production

Treatment of murine cells chronically infected with mouse mammary tumor virus with interferon resulted in a marked inhibition of extracellular virus production. This inhibition occurred despite the lack of effect on the transcription or translation of viral RNA. Interferon treatment did not alter the steady-state level of intracellular viral RNA as determined by hybridization of total cellular and polysomal poly(A) containing RNA with mouse mammary tumor virus complementary DNA. Additionally, analyses by polyacrylamide gel electrophoresis showed no differences in the molecular weights of the major viral proteins in extracts from control and interferon treated cultures. These results are consistent with suggestions that the interferon inhibits production of mouse mammary tumor virus at a late stage of replication.